Contact Us

+350 20079000 info@hassans.gi

This data will only be used by Hassans for processing your query and for no other purpose. View our privacy policy

Time to pay attention to Psychedelic Medicine says The Motley Fool

As previously highlighted in other posts, investors should keep an eye out for stocks in the psychedelic medicine space. Mind Medecine, Compass Pathways and Field Trip Ventures are all candidates to go public in the next 12 months. 

Are we with psychedelic medicine where we were with cannabis 10-15 years ago?

What's important to understand is that a paradigm shift is starting to taking shape within the Western medical community. In effect, scientists are increasingly intrigued by the therapeutic potential of psychedelics as treatments for a whole range of mental health disorders. Pyschedelic medicine thus has the potential to be a gold mine for early investors. www.fool.com/...

GFSC publishes Guidance Note on the assessment of acquisitions and increases in control over Gibraltar regulated firms.

Yesterday, 1 June 2026, the Gibraltar Financial Services Commission ("GFSC") published its Guidance Note on the assessment of...

Posted on
Read more

Latest Insights

Hassans advises Balaena Group, the owner of Gibdock, on acquisition of APCL Group.

Hassans is pleased to have advised Balaena Group a Gibraltar based group (owners of Gibdock) on the acquisition of British marine...

Posted on
Read more

The constitutionality of methods of influence used by the UK in imposing OECD tax reform on Crown Dependencies and Overseas Territories.

Earlier this week, the FT reported that the UK is applying pressure to the Overseas Territories (OTs) to increase "transparency".There...

Posted on
Read more

GFSC publishes Guidance Note on the assessment of acquisitions and increases in control over Gibraltar regulated firms.

Yesterday, 1 June 2026, the Gibraltar Financial Services Commission ("GFSC") published its Guidance Note on the assessment of...

Posted on
Read more